One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally.

Emily Fontaine is the global head of venture capital at IBM. The company’s venture fund, IBM Ventures, is a $500 million fund ...

I’ve learned — sometimes the hard way — that the difference between a startup that lasts and one that fizzles isn’t charisma, ...

LA tax preparation firm Rivet, which has already filed 1,000+ returns, secured a $5.1M seed round led by XYZ Ventures. Read ...

Invisible Technologies founder Francis Pedraza shares advice about crafting the right business model, hiring the right team, ...

It is one of more than three dozen tribal colleges and universities across the country that the Trump administration proposed ...

Hedge fund manager explains how poker prepares you for trading. 📲 Follow @daytrading for daily updates on crypto, stocks, ...

The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, ...

World-leading Music and Dance schools in England are facing a financial crisis that threatens to shut down opportunities for ...

A longtime holding in many of our small-cap funds, Shift4 is a U.S. company that provides payment processing solutions for ...

Harrow’s accelerating revenue and expanding product portfolio may help explain why a fundamentals-focused investment firm ...

Vanderbilt was one of nine schools receiving a Trump administration offer in October: a shot at priority federal grant ...